423 related articles for article (PubMed ID: 18050184)
1. The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom.
Smitten AL; Choi HK; Hochberg MC; Suissa S; Simon TA; Testa MA; Chan KA
Arthritis Rheum; 2007 Dec; 57(8):1431-8. PubMed ID: 18050184
[TBL] [Abstract][Full Text] [Related]
2. No increased risk of herpes zoster in TNF inhibitor and non-TNF inhibitor users with rheumatoid arthritis: epidemiological study using the Japanese health insurance database.
Sakai R; Kasai S; Hirano F; Harada S; Kihara M; Yokoyama W; Tsutsumino M; Nagasaka K; Koike R; Yamanaka H; Miyasaka N; Harigai M
Int J Rheum Dis; 2018 Sep; 21(9):1670-1677. PubMed ID: 29667330
[TBL] [Abstract][Full Text] [Related]
3. Association between the initiation of anti-tumor necrosis factor therapy and the risk of herpes zoster.
Winthrop KL; Baddley JW; Chen L; Liu L; Grijalva CG; Delzell E; Beukelman T; Patkar NM; Xie F; Saag KG; Herrinton LJ; Solomon DH; Lewis JD; Curtis JR
JAMA; 2013 Mar; 309(9):887-95. PubMed ID: 23462785
[TBL] [Abstract][Full Text] [Related]
4. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents.
Strangfeld A; Listing J; Herzer P; Liebhaber A; Rockwitz K; Richter C; Zink A
JAMA; 2009 Feb; 301(7):737-44. PubMed ID: 19224750
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for herpes zoster in rheumatoid arthritis patients: the role of tumour necrosis factor-α inhibitors.
Segan J; Staples MP; March L; Lassere M; Chakravarty EF; Buchbinder R
Intern Med J; 2015 Mar; 45(3):310-8. PubMed ID: 25565419
[TBL] [Abstract][Full Text] [Related]
6. Herpes Zoster Reactivation in Patients With Rheumatoid Arthritis: Analysis of Disease Characteristics and Disease-Modifying Antirheumatic Drugs.
Pappas DA; Hooper MM; Kremer JM; Reed G; Shan Y; Wenkert D; Greenberg JD; Curtis JR
Arthritis Care Res (Hoboken); 2015 Dec; 67(12):1671-8. PubMed ID: 26018115
[TBL] [Abstract][Full Text] [Related]
7. Risk and severity of herpes zoster in patients with rheumatoid arthritis receiving different immunosuppressive medications: a case-control study in Asia.
Liao TL; Chen YM; Liu HJ; Chen DY
BMJ Open; 2017 Jan; 7(1):e014032. PubMed ID: 28057661
[TBL] [Abstract][Full Text] [Related]
8. The risk of hospitalized infection in patients with rheumatoid arthritis.
Smitten AL; Choi HK; Hochberg MC; Suissa S; Simon TA; Testa MA; Chan KA
J Rheumatol; 2008 Mar; 35(3):387-93. PubMed ID: 18260176
[TBL] [Abstract][Full Text] [Related]
9. Antirheumatic drugs and the risk of tuberculosis.
Brassard P; Kezouh A; Suissa S
Clin Infect Dis; 2006 Sep; 43(6):717-22. PubMed ID: 16912945
[TBL] [Abstract][Full Text] [Related]
10. Incidence and time trends of herpes zoster in rheumatoid arthritis: a population-based cohort study.
Veetil BM; Myasoedova E; Matteson EL; Gabriel SE; Green AB; Crowson CS
Arthritis Care Res (Hoboken); 2013 Jun; 65(6):854-61. PubMed ID: 23281295
[TBL] [Abstract][Full Text] [Related]
11. Rates and predictors of herpes zoster in patients with rheumatoid arthritis and non-inflammatory musculoskeletal disorders.
Wolfe F; Michaud K; Chakravarty EF
Rheumatology (Oxford); 2006 Nov; 45(11):1370-5. PubMed ID: 17003175
[TBL] [Abstract][Full Text] [Related]
12. Significant Associations of Neurological Complications of Herpes Zoster With Stroke in Rheumatoid Arthritis Patients.
Liao TL; Lin CH; Chen HH; Chen YM; Lin CC; Chen DY
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28724649
[TBL] [Abstract][Full Text] [Related]
13. Association Between Medications and Herpes Zoster in Japanese Patients with Rheumatoid Arthritis: A 5-year Prospective Cohort Study.
Harada S; Sakai R; Hirano F; Miyasaka N; Harigai M;
J Rheumatol; 2017 Jul; 44(7):988-995. PubMed ID: 28412701
[TBL] [Abstract][Full Text] [Related]
14. Increased risk of opportunistic infection in early rheumatoid arthritis.
Kim H; Cho SK; Lee J; Bae SC; Sung YK
Int J Rheum Dis; 2019 Jul; 22(7):1239-1246. PubMed ID: 31090187
[TBL] [Abstract][Full Text] [Related]
15. Incidence of Herpes Zoster in Patients With Rheumatoid Arthritis in the United States: A Retrospective Cohort Study.
Singer D; Thompson-Leduc P; Poston S; Gupta D; Cheng WY; Ma S; Devine F; Duh MS; Curtis JR
J Rheumatol; 2023 Jul; 50(7):873-880. PubMed ID: 36725054
[TBL] [Abstract][Full Text] [Related]
16. Incidence of herpes zoster in Japanese patients with rheumatoid arthritis from 2005 to 2010.
Nakajima A; Urano W; Inoue E; Taniguchi A; Momohara S; Yamanaka H
Mod Rheumatol; 2015 Jul; 25(4):558-61. PubMed ID: 25648973
[TBL] [Abstract][Full Text] [Related]
17. Risks of herpes zoster in patients with rheumatoid arthritis according to biologic disease-modifying therapy.
Yun H; Xie F; Delzell E; Chen L; Levitan EB; Lewis JD; Saag KG; Beukelman T; Winthrop K; Baddley JW; Curtis JR
Arthritis Care Res (Hoboken); 2015 May; 67(5):731-6. PubMed ID: 25201241
[TBL] [Abstract][Full Text] [Related]
18. Incidence and risk factors for herpes zoster among patients with inflammatory bowel disease.
Gupta G; Lautenbach E; Lewis JD
Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1483-90. PubMed ID: 17162240
[TBL] [Abstract][Full Text] [Related]
19. Newer disease-modifying antirheumatic drugs and the risk of serious hepatic adverse events in patients with rheumatoid arthritis.
Suissa S; Ernst P; Hudson M; Bitton A; Kezouh A
Am J Med; 2004 Jul; 117(2):87-92. PubMed ID: 15234643
[TBL] [Abstract][Full Text] [Related]
20. Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis.
Solomon DH; Massarotti E; Garg R; Liu J; Canning C; Schneeweiss S
JAMA; 2011 Jun; 305(24):2525-31. PubMed ID: 21693740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]